MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What's Driving Day One's Recent Surge? The Servier Acquisition Explained.

1 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does Servier's $2.5 Billion Acquisition Mean for Day One Biopharmaceuticals

2 months ago

What Just Happened with Day One Biopharmaceuticals and Servier

2 months ago

Why Did Servier Pay a 68% Premium for Day One Biopharmaceuticals

1 months ago

What's Driving AltC Acquisition's Recent Surge

1 week ago

Why Urban One Stock Is Skyrocketing Friday

Urban One (UONE/UONEK) shares surged Friday following the company's announcement to acquire two Dallas radio stations. The strategic portfolio shift includes the simultaneous divestiture of an existin...

UONE

Stock News•1 week ago

AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum

Agios Pharmaceuticals shares rose 13% after Q1 revenue surged 138% year-over-year. The growth was driven by the successful launch of Aqvesme and continued sales momentum for Pyrukynd, alongside progre...

AGIO

Stock News•1 week ago

Why Celcuity Stock Popped on Monday

Celcuity shares rose on Monday following the initiation of analyst coverage on the biotech firm. The new coverage serves as the primary catalyst for the stock's recent upward price movement.

CELC

Stock News•1 week ago

Sun Pharma signs Definitive Agreement to Acquire Organon

Sun Pharma agreed to acquire Organon for $14.00 per share in an all-cash transaction. The deal values Organon at an enterprise level, marking a significant consolidation move for the pharmaceutical co...

OGN